Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v10-FR
Language French French
Date Updated 2023-01-25 2023-01-25
Drug Identification Number 02125226 02125226
Brand name NIDAGEL NIDAGEL
Common or Proper name NIDAGEL NIDAGEL
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients METRONIDAZOLE METRONIDAZOLE
Strength(s) 0.75% 0.75%
Dosage form(s) GEL GEL
Route of administration VAGINAL VAGINAL VAGINAL VAGINAL
Packaging size 70g 70g
ATC code G01AF G01AF
ATC description ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST. ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-11-21 2022-11-21
Actual start date 2022-11-04 2022-11-04
Estimated end date 2023-01-26 2023-01-26
Actual end date 2023-01-23 2023-01-23
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Capacity Problem in Production Capacity Problem in Production
Health Canada comments